What Is Known and What Is Still Unknown About the Russian Plague

The term “Russian plague” can refer to both historic outbreaks in Russia and to the fact that Yersinia pestis—the bacterium that causes plague—still circulates in natural reservoirs across parts of Russia and neighboring regions. Below is a summary, drawing on WHO, CDC and peer-reviewed studies, of what we know and what remains uncertain.

---

What Is Known About the Russian Plague

• Causative agent:
  Yersinia pestis is the bacterium responsible for bubonic, septicemic and pneumonic plague. It has been identified in human patients, rodents and fleas in several Russian regions.

• Historic outbreaks:

  • The Moscow plague (1770–1772) killed an estimated 100,000–300,000 people.
  • Sporadic outbreaks occurred in the late 19th and early 20th centuries.

• Natural reservoirs and geography:

  • Plague foci (natural areas where the bacterium persists) are documented in Siberia, the Altai and Baikal regions, and parts of Central Asia.
  • Common reservoir species include marmots, ground squirrels and other wild rodents.
  • Flea species (e.g., Xenopsylla cheopis) transmit the bacterium from rodents to humans.

• Transmission modes:

  • Bubonic plague: bite from an infected flea, leading to swollen lymph nodes (buboes).
  • Septicemic plague: bacteria multiply in the bloodstream, potentially without preceding buboes.
  • Pneumonic plague: inhalation of infected droplets; the most dangerous form, capable of person-to-person spread.

• Clinical presentation:

  • Incubation period: 1–7 days.
  • Key symptoms: sudden fever, chills, headache, fatigue, pain and swelling of lymph nodes (buboes).
  • Without prompt treatment, mortality can exceed 50% in bubonic plague and nearly 100% in septicemic or pneumonic plague.

• Diagnosis:

  • Laboratory confirmation via culture of Y. pestis from bubo fluid, blood or sputum.
  • PCR assays and serology help identify cases in field settings.

• Treatment:

  • First-line antibiotics: streptomycin, gentamicin, doxycycline, or ciprofloxacin.
  • Early antibiotic therapy reduces mortality dramatically (to below 10% in treated bubonic plague).

• Prevention and control:

  • Rodent and flea control in endemic areas.
  • Use of personal protective equipment (PPE) for laboratory or healthcare workers.
  • Isolation of pneumonic plague cases to prevent outbreaks.
  • An FDA-approved live attenuated vaccine exists in some countries but is not widely used in Russia.

• Surveillance:

  • Russian public health authorities monitor animal reservoirs and report human cases.
  • International collaboration with WHO and neighboring countries tracks cross-border spread.

---

What Is Still Unknown About the Russian Plague

• True prevalence in remote areas:
  Sparse healthcare access and underreporting mean we may not know how many mild or subclinical cases occur each year in Siberia and Central Asia.

• Impact of climate change:

  • Warming temperatures and altered precipitation could expand rodent habitats and flea populations.
  • The extent to which these shifts will affect future human risk remains uncertain.

• Antibiotic resistance potential:

  • To date, Y. pestis strains remain largely susceptible to recommended antibiotics.
  • Ongoing surveillance is needed to detect any emerging resistant variants.

• Genetic diversity of local strains:

  • Whole-genome sequencing has revealed multiple Y. pestis lineages in Russia’s foci.
  • The full spectrum of genetic variation and its impact on virulence or transmissibility is still being studied.

• Permafrost thaw and ancient strains:

  • Thawing permafrost may release ancient Y. pestis preserved in rodent carcasses.
  • It is not yet clear whether such reawakened strains could infect modern rodents or humans.

• Risk of urban outbreaks:

  • Most current cases are rural and linked to wildlife exposure.
  • Whether plague could spark a sustained urban outbreak under modern conditions is unknown, though much less likely than during pre-antibiotic eras.

• Long-term immunity in exposed populations:

  • Residents of plague-endemic areas may develop partial immunity over time.
  • The duration and protective effect of this immunity have not been fully quantified.

• Effectiveness of current surveillance networks:

  • Cross-border surveillance exists, but resource constraints limit coverage in sparsely populated regions.
  • Evaluations of surveillance sensitivity and timeliness are ongoing.

---

Staying Informed and Taking Action

Plague remains one of the world’s most infamous infectious diseases, but thanks to modern antibiotics, early diagnosis and public health measures, it is no longer the scourge it once was. If you travel to or live in areas with known plague reservoirs, consider these steps:

1. Wear insect repellent and protective clothing when in rodent-infested areas.
2. Avoid handling sick or dead animals.
3. Seek medical attention if you develop fever and swollen lymph nodes after potential exposure.

You might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/). And always speak to a doctor about anything that could be life threatening or serious.